RHEM
RHEM
Discover our platform in detail
RHEM : Presentation
Montpellier Experimental Histology Network (RHEM), created in 2008, is a platform specialized in histological processing, histological phenotyping, and anatomo-pathological analysis of tissues from experimental animal models of human diseases.
RHEM contributes to preclinical research in order to:
- Better understand the pathophysiological mechanisms of diseases,
- Assess the safety and efficacy of new therapies,
- Identify new pathogenic or therapeutic targets.
By pooling human resources, equipment, and expertise, RHEM constitutes a unique resource for histological and anatomo-pathological analysis for the research stakeholders of Montpellier and the surrounding region.
Services and Integration within the Scientific Ecosystem
The platform also provides a scientific expertise upstream of experiments, support in result interpretation, methodological advice, as well as training in histology and immunohistology. It develops innovative technologies for the characterization of experimental models and constitutes a BioBank of healthy and pathological experimental tissues.
RHEM is part of a dynamic network and acts as a link between several strategic platforms:
- the Montpellier Animal Facilities Network (RAM),
- Montpellier Small Animal Imaging (IPAM),
- and Montpellier Ressources Imaging (MRI).
All of them are federated within BioCampus Montpellier.

Our missions
Institutional Support and Funding
Our network is strongly supported by our supervisory institutions (CNRS, INSERM, and the University of Montpellier) as well as the Grand South-West Cancer Cluster, SiRIC MONTPELLIER Cancer, IBiSA (Infrastructure in Biology, Health, and Agronomy), the French League Against Cancer, the Occitanie-Méditerranée region, and Europe.

RHEM : Organization
The RHEM Network is a multi-site platform based on three technical facilities located across three distinct campuses, and associated with five research institutes:
- Arnaud de Villeneuve Campus (AdV), bringing together the IGF (Institute of Functional Genomics) and the IGH (Institute of Human Genetics)
- IGMM (Institute of Molecular Genetics of Montpellier)
- IRCM (Montpellier Cancer Research Institute)
This network organization allows the pooling of expertise and equipment while ensuring broad coverage of experimental histology needs.
The services offered by RHEM are accessible to the entire scientific community, whether academic researchers or industrial partners.

We also offer lesion analysis by a veterinary pathologist.
The highly qualified staff of these facilities work in close synergy to provide solutions tailored to researchers’ needs.
The strategic directions of the network are defined by a steering committee composed of the scientific and technical managers of the partner structures.
RHEM : Quality Management System

Since 2019, in collaboration with the Quality Department of BioCampus Montpellier, RHEM has implemented a Quality Management System (QMS).
The objective of this initiative is twofold:
- to continuously improve the platform’s operations and expertise,
- to adapt its organization and output to the expectations of users, while providing the team with optimized working conditions.
In December 2022, the RHEM IRCM facility obtained ISO 9001:2015 certification, coupled with NFX 50-900 certification (for its R&D section). The other RHEM facilities have also implemented a quality management approach.
RHEM : Organization chart
Direction de la plateforme RHEM
- Florence BERNEX (MC, UM, 15%)
Responsable Scientifique :
- Nelly PIROT (IR, INSERM, 20%)
Responsable opérationnel :
- Yohan NOEL (IE, INSERM, 15%)
Responsable management qualité :
Comité de Direction
- Florence BERNEX
- Iria GONZALEZ-DOPESO-REYES
- Anne GUILLOU-DUVOID
- Hélène HIRBEC
- Matthieu LACROIX
- Valerie PINET
- Nelly PIROT
Comité d'orientation scientifique et technique
- Marie-Anne COLLE (Oniris, Nantes)
- Alain FAUTREL (Université Rennes1, Rennes)
- Annick PRIGENT (Institut du Cerveau, Paris)
Experts externes :
- Virginie GEORGET (CRBM, Montpellier)
- Vanessa GUILLAUMON (Siric Montpellier Cancer (sponsor), Montpellier)
- Camille MARTINAND-MARI (ISEM, Montpellier)
- Danièle NOEL (IRMB, Montpellier)
- Mirelle-Ange PISTRE (Région Occitanie (Sponsor), Montpellier)
- Valérie RIGAU (CHU, Montpellier)
Experts locaux :
RHEM - IRCM
- Matthieu LACROIX (CR, INSERM, 10%)
Responsable Scientifique :
- Nelly PIROT (IR, INSERM, 80%)
Responsable Technique :
- Florence BERNEX (MC, UM, 35%)
- Aurélie COVINHES (AI, CNRS, 100%)
- Yohan NOEL (IE, INSERM, 85%)
Personnel plateau permanent :
- Morgane BROYON (CDD AI, ICM, 100%)
- Hanane MANSOURI EL YAMANI (CDD IE, CNRS, 100%)
Personnel plateau CDD :
RHEM - IGMM/CRBM
- Valerie PINET (CR, INSERM, 10%)
Responsable Scientifique :
- Iria GONZALEZ-DOPESO-REYES (IR, CNRS, 50%)
Responsable Technique :
- Laura CANTIN - SORO (T, UM, 20%)
Personnel plateau permanent :
- Valentin GARCIA (CDD IE, CNRS, 60%)
- Amy MOREL (CDD T, UM, 100%)
Personnel plateau CDD :
RHEM - ADV
- Hélène HIRBEC (DR, CNRS, 10%)
Responsable Scientifique :
- Anne GUILLOU-DUVOID (AI, CNRS, 100%)
Responsable Technique :
- Stéphanie DEJARDIN (IE, CNRS, 10%)
- Chantal RIPOLL (IR, INSERM, 20%)
Personnel plateau permanent :
- Valentin GARCIA (CDD IE, CNRS, 40%)
Personnel plateau CDD :


